| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TTSH | Common Stock | Sale | -$56.9K | -9.1K | -7.51% | $6.25 | 112K | Nov 21, 2023 | Direct | F1, F2 |
| transaction | TTSH | Common Stock | Sale | -$5.13K | -820 | -100% | $6.25 | 0 | Nov 21, 2023 | By Child #1 | |
| transaction | TTSH | Common Stock | Sale | -$4.84K | -775 | -100% | $6.25 | 0 | Nov 21, 2023 | By Child #2 | |
| transaction | TTSH | Common Stock | Sale | -$4.78K | -765 | -100% | $6.25 | 0 | Nov 21, 2023 | By Child #3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | TTSH | Stock Option (Right to Buy) | 5.4K | Nov 21, 2023 | Common Stock | 5.4K | $8.50 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Includes (i) 3,561 shares of restricted stock for which the risks of forfeiture will lapse on 3/16/24; (ii) 2,540 shares of restricted stock for which the risks of forfeiture will lapse on 3/15/24; (iii) 5,137 shares of restricted stock for which the risks of forfeiture will lapse in equal annual installments on each of 3/7/24 and 3/7/25; (iv) 9,260 shares of restricted stock for which the risks of forfeiture will lapse in equal annual installments on each of 3/6/24, 3/6/25 and 3/6/26; and |
| F2 | (v) the following shares of performance-based restricted stock, which are, in each case, subject to Mr. Davis remaining in continuous employment with the Issuer through December 31 of the year preceding the applicable vesting date and the Issuer achieving its performance target for each respective year: (A) 6,085 shares for which the risks of forfeiture will lapse on the date the Issuer files its annual report for the 2023 fiscal year; (B) 10,788 shares for which the risks of forfeiture will lapse as to 30% and 40% of the initial number of shares granted on each of the dates the Issuer files its annual report for the 2023 and 2024 fiscal years, respectively; and (C) 18,519 shares for which the risks of forfeiture will lapse as to 30%, 30% and 40% on each of the dates the Issuer files its annual report for the 2023, 2024 and 2025 fiscal years, respectively. The Issuer's proxy statement contains additional information regarding the applicable performance targets. |
| F3 | Fully exercisable. |